Munc13-4-STX7 inhibitors impair endosomal TLR activation and systemic inflammation.

Inhibiting Munc13-4-STX7 interaction with ENDO12 reduces endosomal TLR activation and systemic inflammation, decreasing key inflammatory mediators.

• Why it matters: Endosomal TLR signaling is crucial for detecting nonself nucleic acids and initiating immune responses, but overactivation can lead to harmful inflammation, highlighting the need for targeted regulation.
• What they did: Using high-throughput screening, researchers identified small-molecule ENDOs that specifically block Munc13-4-STX7 interaction, impairing endosomal flux and TLR signaling in immune cells, with ENDO12 being the most potent.
• The result: ENDO12 effectively suppressed primary dendritic cell responses to TLR3, TLR7, and TLR9, and reduced CpG-induced systemic inflammation, offering potential therapeutic avenues for inflammatory diseases.